Cirrhosis, Hepatocellular Carcinoma
Conditions
Brief summary
The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
Interventions
This alert prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
Sponsors
Study design
Eligibility
Inclusion criteria
* cirrhosis diagnosis, * 6 months or more after since most recent imaging.
Exclusion criteria
* previous liver transplant, * HCC diagnosis, * receiving hospice care, * completed external imaging in the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of Participants for whom the Physician Completed Ordering of the Pending Liver Ultrasound | Day 1 |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of Participants with Completed Liver Ultrasound Imaging | Day 1 |
| HCC Diagnosis Rate from Completed Liver Ultrasound Imaging | Day 1 |
Countries
United States
Contacts
NYU Langone Health